CMS Covers Power Seat Elevation on Complex Rehab Power Wheelchairs — What Billing Teams Need to Know
CMS updated National Coverage Determination (NCD) 376 to formalize Medicare coverage of power seat elevation equipment used with complex rehabilitative power-driven wheelchairs, with a policy modification date of March 12, 2026. The underlying coverage criteria—originally established effective May 16, 2023—remain intact, but billing and RCM teams need to understand exactly what CMS requires to support a clean claim and avoid costly denials on this Durable Medical Equipment (DME) benefit.
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Seat Elevation Equipment (Power Operated) on Power Wheelchairs |
| Policy Code | NCD 376 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | High |
| Specialties Affected | Physical therapy, occupational therapy, complex rehab technology suppliers, DMEPOS suppliers, PM&R, neurology |
| Key Action | Confirm that all claims for power seat elevation include a qualifying specialty evaluation and documentation of at least one covered transfer or MRADL indication before submitting to the DME MAC. |
What Changed in CMS NCD 376 for Power Seat Elevation Equipment
The Centers for Medicare & Medicaid Services modified NCD 376, which governs Medicare coverage of power-operated seat elevation equipment on power wheelchairs. The core coverage rules—effective for dates of service on or after May 16, 2023—are now reflected in the updated policy version (376-v1). For billing teams, this means the documentation requirements described below are not aspirational guidance; they are the medical necessity standard CMS has codified.
Power seat elevation equipment raises and lowers the user while they remain seated, using an electromechanical lift system that varies seat-to-floor height. Critically, CMS notes that this equipment does not alter seated angles or tilt relative to the ground—a distinction that matters for coding and documentation purposes when differentiating seat elevation from tilt-in-space or recline systems.
CMS Medical Necessity Criteria: Two Requirements That Must Both Be Met
To qualify for Medicare coverage under NCD 376, two conditions must both be satisfied. Think of these as a two-part gate—missing either one is a denial waiting to happen.
Condition 1: Specialty Evaluation
The individual must have undergone a specialty evaluation confirming their ability to safely operate seat elevation equipment in the home. This evaluation must be performed by a licensed or certified medical professional—specifically a physical therapist (PT), occupational therapist (OT), or another practitioner with specific training and experience in rehabilitation wheelchair evaluations.
This is not a standard physician order. A general prescription from a referring physician does not satisfy this requirement. The evaluating clinician must have documented rehabilitation wheelchair evaluation expertise, and that credential should be explicit in the documentation submitted with or retained to support the claim.
Condition 2: At Least One of Three Clinical Indications
Beyond the specialty evaluation, at least one of the following must apply:
| # | Covered Indication |
|---|---|
| 1 | Weight-bearing transfers — The individual performs weight-bearing transfers to or from the power wheelchair at home, using upper extremities during a non-level (uneven) sitting transfer and/or lower extremities during a sit-to-stand transfer. Transfers may involve caregiver assistance and/or assistive equipment such as a sliding board, cane, crutch, or walker. |
| 2 | Non-weight-bearing transfers — The individual requires a dependent transfer (non-weight-bearing) to or from the wheelchair at home, accomplished with or without a floor or mounted lift. |
| 3 | Reaching for MRADLs — The individual performs reaching from the wheelchair to complete one or more mobility-related activities of daily living (MRADLs)—including toileting, feeding, dressing, grooming, and bathing—in customary locations within the home. Caregiver assistance and assistive equipment are permitted. |
Each of these indications speaks directly to functional need in the home environment. Documentation must reflect home-based use, not workplace or community access needs.
Coverage Scope: Complex Rehab vs. Standard Power Wheelchairs
This is one of the most important distinctions in NCD 376, and one billing teams must get right.
The nationally covered indication under this NCD applies specifically to complex rehabilitative power-driven wheelchairs, as defined in 42 CFR §414.202. Standard power wheelchairs do not qualify under these national coverage criteria.
However, CMS does leave a door open: the Durable Medical Equipment Medicare Administrative Contractor (DME MAC) retains discretion to determine reasonable and necessary coverage of power seat elevation equipment for individuals using Medicare-covered power wheelchairs that are not complex rehabilitative power-driven wheelchairs. This means coverage for non-CRT power wheelchair users is a local determination—and billing teams should check their DME MAC's local coverage determinations (LCDs) and policy articles before submitting those claims.
There are no nationally non-covered indications listed in this NCD.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The policy does not list specific HCPCS or CPT codes in this version of NCD 376. Billing teams should consult their DME MAC's applicable LCD and policy article—referenced in the cross-references to Medicare Claims Processing Manual, Chapters 20 and 23—for the current HCPCS codes used to bill power seat elevation equipment. Cross-reference with the Medicare Benefit Policy Manual, Chapter 15, for benefit category confirmation.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit your documentation checklist immediately. Confirm that your intake and prior authorization workflows for power wheelchair accessories require a specialty evaluation from a PT, OT, or credentialed rehabilitation wheelchair evaluator—not just a physician order. Add a field that captures the evaluator's specific credentials and training. |
| 2 | Verify the wheelchair type before billing. Before submitting any seat elevation claim, confirm the base wheelchair qualifies as a complex rehabilitative power-driven wheelchair under 42 CFR §414.202. If the beneficiary uses a standard power wheelchair, contact your DME MAC for guidance on local coverage before proceeding. |
| 3 | Document the specific transfer or MRADL indication. Your clinical notes must explicitly address which of the three covered indications applies. Vague language like "patient needs assistance with transfers" will not hold up in a post-payment audit. Document the transfer type (weight-bearing vs. non-weight-bearing), the assistive equipment used if any, caregiver involvement, and the home environment context. |
| 4 | Pull your DME MAC's LCD and policy article now. Since NCD 376 does not enumerate specific HCPCS codes, the applicable billing codes live in your regional DME MAC's documents. Retrieve these before the March 12, 2026 effective date and share them with your coding team. |
| 5 | Flag pending claims that predate compliant documentation. If you have seat elevation claims in process where the evaluation or clinical indication documentation doesn't meet these criteria, pause those claims and request updated documentation from the ordering provider before submitting. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.